search
Back to results

Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine

Primary Purpose

Migraine With Aura, Migraine Without Aura

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Sham chiropractic manipulative therapy
Chiropractic spinal manipulative therapy
Sponsored by
University Hospital, Akershus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Migraine With Aura

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Migraine according to the diagnostic criteria of the ICHD-II (8)
  • At least one migraine attack per month
  • Age 18-70 years

Exclusion Criteria:

  • Contraindication to spinal manipulation
  • Chiropractic treatment within the last 12 months
  • Radiculopathy
  • Depression
  • Pregnancy
  • Participants whom become pregnant during the migraine trial will also be excluded from analysis from the time of pregnancy
  • Participants who change their prophylactic medical regime for headaches will be excluded in the analysis from the time of change

Sites / Locations

  • Research Centre, Akershus University Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Sham Comparator

No Intervention

Arm Label

Chiropractic Spinal Manipulative Therapy

Sham manipulation

Control group

Arm Description

Active chiropractic spinal manipulative treatment

Sham chiropractic manipulative therapy

No intervention, follow headache diary

Outcomes

Primary Outcome Measures

Number og headache days
25% reduction in number of headache days between active treatment and sham. 25% reduction in number of headache days between active treatment and control group.

Secondary Outcome Measures

Headache duration
25% reduction in headache duration in hours between active treatment and sham. 25% reduction in headache duration in hours between active treatment and control group.
Self reported VAS
25% self-reported improvement on VAS between active treatment and sham. 25% self-reported improvement on VAS between active treatment and control group.
Headache index
25% reduction in headache index (frequency x duration x intensity) between active treatment and sham. 25% reduction in headache index between active treatment and control group.
Headache medication
50% reduction in headache medication between active treatment and sham. 50% reduction in headache medication between active treatment and control group.

Full Information

First Posted
December 2, 2012
Last Updated
January 9, 2019
Sponsor
University Hospital, Akershus
Collaborators
Norwegian Foundation for Health and Rehabilitation, Norwegian Chiropractic Association
search

1. Study Identification

Unique Protocol Identification Number
NCT01741714
Brief Title
Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine
Official Title
Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine? A Randomized Controlled Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
February 2013 (undefined)
Primary Completion Date
March 2015 (Actual)
Study Completion Date
September 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Akershus
Collaborators
Norwegian Foundation for Health and Rehabilitation, Norwegian Chiropractic Association

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will highlight and validate chiropractic spinal manipulative therapy (CSMT) for migraine. If the method proves to be effective, it will provide a new non-pharmacological treatment option for migraine. This is especially important since some migraineurs do not tolerate acute and/or prophylactic medicine, due to side effects or contraindications due to comorbidity of other diseases while others do not have effect. Thus, alternative treatment options are warranted. The applied methodology of the study will aim towards the highest possible research standards. This international study is a collaboration between Akershus University Hospital, University of Oslo (UiO), Norway and Macquarie University, Australia. The multidisciplinary professional backgrounds are physiotherapy, chiropractic and medicine. By increasing the methodological quality of the investigators research to a very high level, the investigators see the method to work as a guide to increase the quality of chiropractic research in the future, as previous randomized clinical trials (RCTs) of migraine used methodology showing room for improvement.
Detailed Description
Migraine is characterized by a unilateral pulsating moderate/severe headache which is aggravated by routine physical activity, and is accompanied by photo- and/or phonophobia, nausea and sometimes vomiting. Migraine exists in two forms, migraine without aura (MO) and migraine with aura (MA). Aura is reversible neurological disturbances of the vision, sensory and/or speech, which occur prior to the headache. The aura symptoms show intra-individual variations. The origin of migraine pain is still debated, since the origin of painful impulses in the trigeminal nerve is still uncertain. Some argues for central and other argues for peripheral mechanisms. Extracranial pain sensitive structures include skin, muscles, arteries, periosteum and joints. The skin is sensitive to all usual forms of pain stimuli, while especially temporal and neck muscles may be sources for pain and tenderness in migraine. Similarly is the frontal supraorbital, superficial temporal, posterior and occipital arteries sensitive to pain. It has been hypothesize that CSMT might relieve migraine due to stimulation of different mechanoreceptors in the neck such as the zygapophyseal joints, intervertebral discs and neck muscles. Numerous studies of manipulations have been conducted, but all had one or more methodological shortcomings, i.e. failure to specify diagnostic criteria, inadequate or no randomization procedure, lack of control, lack of patient blinding, lack of specified primary and secondary end points and shortcomings of statistical evaluation of the results. A few RCTs suggest that CSMT using diversified technique is an effective therapy for migraine. The diversified technique is used by 91% of chiropractors, and include a collections of procedures, hence the name diversified. It focuses on inter-segmental pretension (soft tissue tension) prior to the delivery of high velocity low amplitude (HVLA) adjustment. The Gonstead method is used by 59% of chiropractors and is also based on HVLA, but a major difference is the minimal usage of rotation in all adjustments in contrast to the diversified technique. The Gonstead method is considered safe, since severe adverse reactions have not been encountered. No studies have previously investigated the efficacy of the Gonstead method for migraine, although research in other CSMT modalities has been recommended. Study hypothesis CSMT using the Gonstead method reduces days with migraine by at least 25% as compared to placebo (sham manipulation, i.e. broad non-specific contact, non-directional, low velocity and low amplitude) and no intervention (control group). The RCT is single blinded, placebo-controlled trial of CSMT using the Gonstead method vs. sham manipulation and control group. If the treatment shows to be effective, the participants whom receive sham manipulation or control will be offered true intervention after the follow-up period and free of charge. This study will follow the recommendations set by the clinical trial guidelines from the IHS, while the methodological quality control will in general follow previous suggested criteria and the CONSORT statements. Patients will be recruited through Akershus University Hospital, Norway as well as through media advertising in Akershus and Oslo County. The diagnoses are set by a chiropractor and a neurologist with experience in headache. In accordance with good clinical practice, all patients will receive written and oral information about the project and will be informed about the harms and benefits as well as adverse reaction of the intervention. A total of 90 participants need to be recruited to the clinical trial. The clinical trials consist of three stages: Run-in, intervention (treatment) and follow-up. One month of baseline data collection where participants will fill-in a diagnostic headache diary. Baseline demographics and clinical characteristics will be presented in tables with mean and standard deviation (SD) for each group. As age and genders may plays a role, participants will be subdivided into four subgroups by age and gender prior to the concealed group allocation and restricted randomization by drawing prepared sealed lots. Each lot includes three different interventions, i.e active treatment, sham manipulation and control group. The first three participants will draw from the same lot until all three interventions are used. The next lot with three interventions is then followed by the next three participants; each participant will only receive one intervention. The RCT will be conducted by an experienced chiropractor. Active treatment consists of CSMT using the Gonstead method. A specific contact, high velocity, low amplitude, short lever, with no recoil post adjustment directed to spinal biomechanical dysfunction diagnosed by standard chiropractic tests. Follow-up at 3, 6 and 12 months post-treatment. During this period participants continue to fill in a diagnostic headache diary. The control group will also be included in this phase of the study. The data will be analyzed with SPSS using standard statistical techniques. The investigators based the calculation of sample size on migraine days from recent group comparison studies of topiramate. The investigators calculated that a sample size of 16 patients was required in each group to detect a difference in mean reduction in monthly migraine headache days of 2.5 with 80% power, with p=0.05 as level of significance, and assuming a common SD of 2.5 for active treatment and broad-based treatment groups. Insurance is through "The Norwegian System of Compensation to Patients" (NPE) which is an independent national body, set up to process compensation claims from patients who have suffered an injury as a result of treatment under the Norwegian health service. The Regional Committee for Medical Research Ethics (REK) in Norway and Norwegian Social Science Data Services approved the full PhD research protocol. The declaration of helsinski is followed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Migraine With Aura, Migraine Without Aura

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
104 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Chiropractic Spinal Manipulative Therapy
Arm Type
Active Comparator
Arm Description
Active chiropractic spinal manipulative treatment
Arm Title
Sham manipulation
Arm Type
Sham Comparator
Arm Description
Sham chiropractic manipulative therapy
Arm Title
Control group
Arm Type
No Intervention
Arm Description
No intervention, follow headache diary
Intervention Type
Other
Intervention Name(s)
Sham chiropractic manipulative therapy
Intervention Description
Sham manipulation
Intervention Type
Other
Intervention Name(s)
Chiropractic spinal manipulative therapy
Intervention Description
Chiropractic spinal manipulative therapy
Primary Outcome Measure Information:
Title
Number og headache days
Description
25% reduction in number of headache days between active treatment and sham. 25% reduction in number of headache days between active treatment and control group.
Time Frame
Change from baseline to post-treatment, 3, 6, 12 months follow-up
Secondary Outcome Measure Information:
Title
Headache duration
Description
25% reduction in headache duration in hours between active treatment and sham. 25% reduction in headache duration in hours between active treatment and control group.
Time Frame
Change from baseline to post-treatment, 3, 6, 12 months follow-up
Title
Self reported VAS
Description
25% self-reported improvement on VAS between active treatment and sham. 25% self-reported improvement on VAS between active treatment and control group.
Time Frame
Change from baseline to post-treatment, 3, 6, 12 months follow-up
Title
Headache index
Description
25% reduction in headache index (frequency x duration x intensity) between active treatment and sham. 25% reduction in headache index between active treatment and control group.
Time Frame
Change from baseline to post-treatment, 3, 6, 12 months follow-up
Title
Headache medication
Description
50% reduction in headache medication between active treatment and sham. 50% reduction in headache medication between active treatment and control group.
Time Frame
Change from baseline to post-treatment, 3, 6, 12 months follow-up
Other Pre-specified Outcome Measures:
Title
Sub analysis on x-ray findings
Description
As there are no validated x-ray assessment forms a descriptive sub-analysis will be done on participants with structural deformities vs. normal x-ray findings. Structural deformities include postural assessment, joint and disc integrity, vertebral misalignments and ruling out pathology prior to CSMT.
Time Frame
Pre-treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Migraine according to the diagnostic criteria of the ICHD-II (8) At least one migraine attack per month Age 18-70 years Exclusion Criteria: Contraindication to spinal manipulation Chiropractic treatment within the last 12 months Radiculopathy Depression Pregnancy Participants whom become pregnant during the migraine trial will also be excluded from analysis from the time of pregnancy Participants who change their prophylactic medical regime for headaches will be excluded in the analysis from the time of change
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael B Russell, Professor
Organizational Affiliation
Head and Neck Research Group, Research Centre, Akershus University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Research Centre, Akershus University Hospital
City
Lørenskog
ZIP/Postal Code
1478
Country
Norway

12. IPD Sharing Statement

Citations:
PubMed Identifier
21298314
Citation
Chaibi A, Tuchin PJ, Russell MB. Manual therapies for migraine: a systematic review. J Headache Pain. 2011 Apr;12(2):127-33. doi: 10.1007/s10194-011-0296-6. Epub 2011 Feb 5.
Results Reference
background
PubMed Identifier
26586317
Citation
Chaibi A, Saltyte Benth J, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for migraine: a study protocol of a single-blinded placebo-controlled randomised clinical trial. BMJ Open. 2015 Nov 19;5(11):e008095. doi: 10.1136/bmjopen-2015-008095.
Results Reference
background
PubMed Identifier
27696633
Citation
Chaibi A, Benth JS, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial. Eur J Neurol. 2017 Jan;24(1):143-153. doi: 10.1111/ene.13166. Epub 2016 Oct 2.
Results Reference
result
PubMed Identifier
26145718
Citation
Chaibi A, Saltyte Benth J, Bjorn Russell M. Validation of Placebo in a Manual Therapy Randomized Controlled Trial. Sci Rep. 2015 Jul 6;5:11774. doi: 10.1038/srep11774.
Results Reference
result
PubMed Identifier
28324697
Citation
Chaibi A, Benth JS, Tuchin PJ, Russell MB. Adverse events in a chiropractic spinal manipulative therapy single-blinded, placebo, randomized controlled trial for migraineurs. Musculoskelet Sci Pract. 2017 Jun;29:66-71. doi: 10.1016/j.msksp.2017.03.003. Epub 2017 Mar 14. Erratum In: Musculoskelet Sci Pract. 2017 Oct;31:21.
Results Reference
result

Learn more about this trial

Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine

We'll reach out to this number within 24 hrs